Sort   by:  
 Page size 
TranscriptomicsTranscription profiling by array of human colorectal cancer epithelial (HCT116) p53 null cells treated with SN38 for 6, 12 and 24h
HCT116 p53 null cells were treated with 5nM SN38 (active metabolite of CPT-11) for 6, 12 and 24h. Following this RNA was harvested for transcriptional profiling.
ORGANISM(S): Homo sapiens 
2007-11-30 | E-MEXP-1194 | biostudies-arrayexpress
UnknownEvaluating trastuzumab deruxtecan in patients with gastrooesophageal adenocarcinoma who are ctDNA and HER2 positive: DECIPHER.
Not available
S-EPMC12836495 | biostudies-literature
UnknownImmune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trial.
Not available
S-EPMC11693431 | biostudies-literature
UnknownResearch priorities for cancers of the oesophagus and stomach: recommendations from a UK and Ireland patient and healthcare professional partnership exercise.
Not available
S-EPMC12703242 | biostudies-literature
UnknownTranscriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.
Not available
S-EPMC6851674 | biostudies-literature
UnknownSpiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation.
Not available
S-EPMC7667836 | biostudies-literature
UnknownMutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.
Not available
S-EPMC5957269 | biostudies-literature
UnknownThe transcriptional landscape of endogenous retroelements delineates esophageal adenocarcinoma subtypes.
Not available
S-EPMC10370457 | biostudies-literature
UnknownTrimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial.
Not available
S-EPMC10567579 | biostudies-literature
UnknownContext-dependent effects of CDKN2A and other 9p21 gene losses during the evolution of esophageal cancer.
Not available
S-EPMC11779637 | biostudies-literature
Sort   by:  
 Page size